GROUP A STREPTOCOCCUS VACCINE
- Summary
- A vaccine for treating or preventing group A streptococcus streptococcus-associated diseases and conditions.
- Technology Benefits
- Vaccine to prevent group A streptococci infection
- Technology Application
- Vaccine - disease prevention
- Detailed Technology Description
- A method and composition for eliciting an immune response to group A streptococcal bacteria in a mammal is provided, which includes administering to the mammal an M protein fragment, variant or derivative thereof and a SpyCEP protein or peptide fragment, or an antibody to the SpyCEP protein or fragment to facilitate restoring or enhancing neutrophil activity. Also provided is an immunodominant peptide fragment of SpyCEP
- Type of Cooperation
- Licensing
- Application Date
- 15/04/2015 00:00:00
- Application No.
- MX/a/2016/013277
IL248266
MYPI2016001815
NZ725212
AU2015246654
SG11201608380P
US15/304462
BR1120160239156
JP2016/562764
EP15779482.7
CA2945052
IN201617038035
KR2016-7031477
IDP00201607493
- Country/Region
- Mexico
For more information, please click Here